Contemporary OB/GYN week in review: mifepristone, HPV vaccine, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: mifepristone, HPV vaccine, and more

Contemporary OB/GYN week in review: mifepristone, HPV vaccine, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, December 11 - Friday, December 15, 2023), and click each link to read and watch anything you may have missed.

1.) Supreme Court to decide access on mifepristone for abortion

The Supreme Court's upcoming decision on mifepristone, a key abortion medication, may alter access, introducing potential restrictions and impacting the landscape of abortion rights.

Click here for the full article.

2.) How COVID-19 impacted HPV vaccination rates in New York City and Long Island

A recent study looks at the impact COVID-19 had on human papillomavirus vaccination rates in New York City and Long Island.

Click here for the full article.

3.) Elevated bilateral salpingo-oophorectomy rates in women with disabilities

A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.

Click here for the full article.

4.) Managing skin health in women

Toby Maurer, MD, professor at University of California, San Francisco, discusses common skin conditions seen in female patients, along with the best methods of treating these conditions.

Click here for the full article.

5.) Evaluating efficacy of active surveillance for CIN2

Discover how active surveillance, a growing approach in managing cervical intraepithelial neoplasia, offers a nuanced alternative to immediate interventions, showcasing promising regression rates and reduced risk of overtreatment.

Click here for the full article.

Recent Videos
Transforming cervical cancer protection with the BD Onclarity HPV Assay | Image Credit: linkedin.com
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
JoAnne Pinkerton, MD, FACOG, NCMP
Nannette Santoro, MD
Lauren Streicher, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.